These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9207000)

  • 21. Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage.
    Levitsky V; Liu D; Southwood S; Levitskaya J; Sette A; Masucci MG
    Hum Immunol; 2000 Oct; 61(10):972-84. PubMed ID: 11082510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
    Gavioli R; Vertuani S; Masucci MG
    Int J Cancer; 2002 Oct; 101(6):532-8. PubMed ID: 12237893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire.
    Lim A; Trautmann L; Peyrat MA; Couedel C; Davodeau F; Romagné F; Kourilsky P; Bonneville M
    J Immunol; 2000 Aug; 165(4):2001-11. PubMed ID: 10925283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
    Levitsky V; de Campos-Lima PO; Frisan T; Masucci MG
    J Immunol; 1998 Jul; 161(2):594-601. PubMed ID: 9670932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
    Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
    J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses.
    Micheletti F; Bazzaro M; Canella A; Marastoni M; Traniello S; Gavioli R
    Immunology; 1999 Mar; 96(3):411-5. PubMed ID: 10233722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.
    Koning D; Costa AI; Hoof I; Miles JJ; Nanlohy NM; Ladell K; Matthews KK; Venturi V; Schellens IM; Borghans JA; Kesmir C; Price DA; van Baarle D
    J Immunol; 2013 Feb; 190(3):931-9. PubMed ID: 23267020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing factors determining immunodominant responses against dominant epitopes.
    Ritmahan W; Kesmir C; Vroomans RMA
    Immunogenetics; 2020 Feb; 72(1-2):109-118. PubMed ID: 31811313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
    Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
    Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
    J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
    de Campos-Lima PO; Gavioli R; Zhang QJ; Wallace LE; Dolcetti R; Rowe M; Rickinson AB; Masucci MG
    Science; 1993 Apr; 260(5104):98-100. PubMed ID: 7682013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR.
    Zhang QJ; Lindquist Y; Levitsky V; Masucci MG
    Int Immunol; 1996 Jun; 8(6):927-38. PubMed ID: 8671682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.
    Miles JJ; Bulek AM; Cole DK; Gostick E; Schauenburg AJ; Dolton G; Venturi V; Davenport MP; Tan MP; Burrows SR; Wooldridge L; Price DA; Rizkallah PJ; Sewell AK
    PLoS Pathog; 2010 Nov; 6(11):e1001198. PubMed ID: 21124993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
    Levitsky V; Zhang QJ; Levitskaya J; Kurilla MG; Masucci MG
    J Immunol; 1997 Dec; 159(11):5383-90. PubMed ID: 9548478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.
    Miles JJ; Thammanichanond D; Moneer S; Nivarthi UK; Kjer-Nielsen L; Tracy SL; Aitken CK; Brennan RM; Zeng W; Marquart L; Jackson D; Burrows SR; Bowden DS; Torresi J; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
    J Immunol; 2011 Jan; 186(2):901-12. PubMed ID: 21160049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
    J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.